Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5955 | 1552 | 55.2 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
578 | 3 | CHEMOKINES//CXCR4//MACROPHAGE MIGRATION INHIBITORY FACTOR | 16225 |
546 | 2 | CHEMOKINES//CXCR4//CHEMOKINE RECEPTOR | 14674 |
5955 | 1 | TUMOR ASSOCIATED MACROPHAGES//TUMOUR ASSOCIATED MACROPHAGES//MACROPHAGE POLARIZATION | 1552 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TUMOR ASSOCIATED MACROPHAGES | authKW | 1586415 | 13% | 40% | 204 |
2 | TUMOUR ASSOCIATED MACROPHAGES | authKW | 310459 | 2% | 48% | 33 |
3 | MACROPHAGE POLARIZATION | authKW | 197485 | 3% | 20% | 51 |
4 | TUMOR ASSOCIATED MACROPHAGES TAMS | authKW | 174850 | 1% | 44% | 20 |
5 | M2 MACROPHAGES | authKW | 168476 | 2% | 24% | 35 |
6 | CD204 | authKW | 103486 | 1% | 48% | 11 |
7 | MACROPHAGES | authKW | 90464 | 21% | 1% | 323 |
8 | CD163 | authKW | 85438 | 2% | 13% | 34 |
9 | M2 POLARIZED MACROPHAGES | authKW | 78693 | 0% | 100% | 4 |
10 | STUDY REPROD BIOL WOMENS HLTH | address | 72623 | 1% | 31% | 12 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 7731 | 37% | 0% | 576 |
2 | Immunology | 6724 | 32% | 0% | 500 |
3 | Cell Biology | 1629 | 18% | 0% | 280 |
4 | Pathology | 542 | 6% | 0% | 92 |
5 | Medicine, Research & Experimental | 492 | 8% | 0% | 120 |
6 | Hematology | 399 | 6% | 0% | 88 |
7 | Respiratory System | 43 | 2% | 0% | 31 |
8 | Biochemistry & Molecular Biology | 29 | 9% | 0% | 135 |
9 | Materials Science, Biomaterials | 19 | 1% | 0% | 13 |
10 | Multidisciplinary Sciences | 14 | 1% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STUDY REPROD BIOL WOMENS HLTH | 72623 | 1% | 31% | 12 |
2 | MYELOID CELL IMMUNOL | 63725 | 1% | 20% | 16 |
3 | MACROPHAGES ENDOTHELIAL CELLS GRP | 59019 | 0% | 100% | 3 |
4 | REPROD BIOL WOMENS HLTH | 54643 | 0% | 56% | 5 |
5 | ANGIOGENESIS TUMOR TARGETING UNIT | 50352 | 1% | 32% | 8 |
6 | INNATE IMMUN TOLERANCE | 44964 | 0% | 57% | 4 |
7 | HUMAN INNATE IMMUN | 39346 | 0% | 100% | 2 |
8 | LUNG CANCCANC HOSPTIANJIN LUNG CANC | 39346 | 0% | 100% | 2 |
9 | TUMOR INFLAMMAT ANGIOGENESIS | 39346 | 0% | 100% | 2 |
10 | DEV MOL BIOL | 28546 | 2% | 4% | 36 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOIMMUNOLOGY | 10853 | 1% | 2% | 23 |
2 | IMMUNOBIOLOGY | 5910 | 2% | 1% | 31 |
3 | ONCOTARGET | 3041 | 3% | 0% | 44 |
4 | JOURNAL OF LEUKOCYTE BIOLOGY | 3028 | 2% | 0% | 33 |
5 | CANCER CELL | 2499 | 1% | 1% | 14 |
6 | NATURE REVIEWS IMMUNOLOGY | 2216 | 1% | 1% | 11 |
7 | FRONTIERS IN IMMUNOLOGY | 2165 | 1% | 1% | 18 |
8 | IMMUNITY | 2040 | 1% | 1% | 19 |
9 | CANCER SCIENCE | 1585 | 1% | 0% | 17 |
10 | NATURE IMMUNOLOGY | 1484 | 1% | 1% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TUMOR ASSOCIATED MACROPHAGES | 1586415 | 13% | 40% | 204 | Search TUMOR+ASSOCIATED+MACROPHAGES | Search TUMOR+ASSOCIATED+MACROPHAGES |
2 | TUMOUR ASSOCIATED MACROPHAGES | 310459 | 2% | 48% | 33 | Search TUMOUR+ASSOCIATED+MACROPHAGES | Search TUMOUR+ASSOCIATED+MACROPHAGES |
3 | MACROPHAGE POLARIZATION | 197485 | 3% | 20% | 51 | Search MACROPHAGE+POLARIZATION | Search MACROPHAGE+POLARIZATION |
4 | TUMOR ASSOCIATED MACROPHAGES TAMS | 174850 | 1% | 44% | 20 | Search TUMOR+ASSOCIATED+MACROPHAGES+TAMS | Search TUMOR+ASSOCIATED+MACROPHAGES+TAMS |
5 | M2 MACROPHAGES | 168476 | 2% | 24% | 35 | Search M2+MACROPHAGES | Search M2+MACROPHAGES |
6 | CD204 | 103486 | 1% | 48% | 11 | Search CD204 | Search CD204 |
7 | MACROPHAGES | 90464 | 21% | 1% | 323 | Search MACROPHAGES | Search MACROPHAGES |
8 | CD163 | 85438 | 2% | 13% | 34 | Search CD163 | Search CD163 |
9 | M2 POLARIZED MACROPHAGES | 78693 | 0% | 100% | 4 | Search M2+POLARIZED+MACROPHAGES | Search M2+POLARIZED+MACROPHAGES |
10 | M1 MACROPHAGES | 63448 | 1% | 32% | 10 | Search M1+MACROPHAGES | Search M1+MACROPHAGES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | QIAN, BZ , POLLARD, JW , (2010) MACROPHAGE DIVERSITY ENHANCES TUMOR PROGRESSION AND METASTASIS.CELL. VOL. 141. ISSUE 1. P. 39 -51 | 55 | 44% | 1125 |
2 | RUFFELL, B , COUSSENS, LM , (2015) MACROPHAGES AND THERAPEUTIC RESISTANCE IN CANCER.CANCER CELL. VOL. 27. ISSUE 4. P. 462 -472 | 58 | 48% | 86 |
3 | DE PALMA, M , LEWIS, CE , (2013) MACROPHAGE REGULATION OF TUMOR RESPONSES TO ANTICANCER THERAPIES.CANCER CELL. VOL. 23. ISSUE 3. P. 277 -286 | 48 | 62% | 220 |
4 | NOY, R , POLLARD, JW , (2014) TUMOR-ASSOCIATED MACROPHAGES: FROM MECHANISMS TO THERAPY.IMMUNITY. VOL. 41. ISSUE 1. P. 49 -61 | 49 | 40% | 304 |
5 | LAOUI, D , VAN OVERMEIRE, E , DE BAETSELIER, P , VAN GINDERACHTER, JA , RAES, G , (2014) FUNCTIONAL RELATIONSHIP BETWEEN TUMOR-ASSOCIATED MACROPNAGES AND MACROPNAGE COLONY-STIMULATING FACTOR AS CONTRIBUTORS TO CANCER PROGRESSION.FRONTIERS IN IMMUNOLOGY. VOL. 5. ISSUE . P. - | 70 | 57% | 27 |
6 | TAKEYA, M , KOMOHARA, Y , (2016) ROLE OF TUMOR-ASSOCIATED MACROPHAGES IN HUMAN MALIGNANCIES: FRIEND OR FOE?.PATHOLOGY INTERNATIONAL. VOL. 66. ISSUE 9. P. 491 -505 | 76 | 55% | 1 |
7 | KEIRSSE, J , LAOUI, D , MOVAHEDI, K , VAN OVERMEIRE, E , VAN GINDERACHTER, JA , LAHMAR, Q , (2016) TISSUE-RESIDENT VERSUS MONOCYTE-DERIVED MACROPHAGES IN THE TUMOR MICROENVIRONMENT.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1865. ISSUE 1. P. 23 -34 | 74 | 43% | 6 |
8 | MANTOVANI, A , ALLAVENA, P , (2015) THE INTERACTION OF ANTICANCER THERAPIES WITH TUMOR-ASSOCIATED MACROPHAGES.JOURNAL OF EXPERIMENTAL MEDICINE. VOL. 212. ISSUE 4. P. 435 -445 | 47 | 48% | 66 |
9 | BISWAS, SK , ALLAVENA, P , MANTOVANI, A , (2013) TUMOR-ASSOCIATED MACROPHAGES: FUNCTIONAL DIVERSITY, CLINICAL SIGNIFICANCE, AND OPEN QUESTIONS.SEMINARS IN IMMUNOPATHOLOGY. VOL. 35. ISSUE 5. P. 585-600 | 64 | 49% | 76 |
10 | MURRAY, PJ , ALLEN, JE , BISWAS, SK , FISHER, EA , GILROY, DW , GOERDT, S , GORDON, S , HAMILTON, JA , IVASHKIV, LB , LAWRENCE, T , ET AL (2014) MACROPHAGE ACTIVATION AND POLARIZATION: NOMENCLATURE AND EXPERIMENTAL GUIDELINES.IMMUNITY. VOL. 41. ISSUE 1. P. 14 -20 | 24 | 55% | 494 |
Classes with closest relation at Level 1 |